Pierre-Yves Scarabin Selected Research

Norpregnanes

11/2010

Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre-Yves Scarabin Research Topics

Disease

24	Venous Thromboembolism 11/2019 - 10/2002
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2018 - 07/2006
6	Stroke (Strokes) 01/2018 - 07/2006
5	Activated Protein C Resistance (APC Resistance) 02/2017 - 10/2002
5	Venous Thrombosis (Deep-Vein Thrombosis) 06/2011 - 04/2003
4	Thrombosis (Thrombus) 01/2014 - 10/2007
4	Coronary Disease (Coronary Heart Disease) 06/2011 - 01/2003
3	Carotid Artery Diseases 01/2018 - 02/2002
3	Neoplasms (Cancer) 01/2017 - 01/2012
3	Dementia (Dementias) 10/2014 - 01/2014
2	Ischemic Stroke 01/2016 - 06/2011
2	Inflammation (Inflammations) 02/2014 - 07/2012
2	Atherosclerotic Plaque (Atheroma) 07/2012 - 01/2003
1	Mental Disorders (Mental Disorder) 01/2020
1	Heart Diseases (Heart Disease) 01/2016
1	Thrombophilia 02/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Obesity 01/2014
1	Cognitive Dysfunction 12/2013
1	Overweight 12/2012
1	Endometrial Neoplasms (Endometrial Cancer) 12/2011
1	Anxiety Disorders (Anxiety Disorder) 11/2011
1	Myocardial Infarction 04/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2011
1	Lung Neoplasms (Lung Cancer) 01/2010
1	Chronic Disease (Chronic Diseases) 07/2006
1	Hypertension (High Blood Pressure) 05/2006
1	Atherosclerosis 02/2002

Drug/Important Bio-Agent (IBA)

21	Hormones (Hormone)IBA 11/2019 - 11/2005
19	Estrogens (Estrogen)FDA Link 02/2016 - 01/2003
10	Progestins (Progestagens)IBA 01/2016 - 03/2005
5	Testosterone (Sustanon)FDA Link 01/2018 - 07/2012
5	Fibrinogen (Factor I)FDA Link 02/2014 - 01/2003
4	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2018 - 06/2012
4	Estradiol (Delestrogen)FDA LinkGeneric 01/2018 - 10/2007
4	Estrogen ReceptorsIBA 01/2014 - 11/2011
3	Progesterone FDA LinkGeneric 11/2019 - 11/2010
3	Protein CIBA 02/2017 - 10/2002
3	Contraceptive Agents (Contraceptives)IBA 02/2017 - 04/2009
3	Thrombin FDA Link 02/2014 - 06/2011
3	Combined Oral ContraceptivesIBA 04/2011 - 04/2009
2	SteroidsIBA 01/2020 - 10/2014
2	factor V LeidenIBA 09/2003 - 10/2002
1	Protein SIBA 02/2017
1	Prothrombin (Factor II)IBA 02/2017
1	AnthracyclinesIBA 01/2016
1	C-Reactive ProteinIBA 02/2014
1	FibrinIBA 02/2014
1	Apolipoproteins E (ApoE)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 08/2011
1	AntithrombinsIBA 03/2011
1	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 03/2011
1	fibrin fragment D (D-dimer)IBA 03/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2011
1	PlasminogenIBA 03/2011
1	Oral ContraceptivesIBA 03/2011
1	NorpregnanesIBA 11/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2009
1	Cytochrome P-450 CYP3AIBA 08/2008
1	Blood Group Antigens (Blood Groups)IBA 01/2008
1	antithrombin Cambridge IIIBA 10/2007
1	Plasminogen InactivatorsIBA 05/2006
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	Triglycerides (Triacylglycerol)IBA 05/2006
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2006
1	Plasminogen Activator Inhibitor 1IBA 05/2006
1	CholesterolIBA 05/2006
1	AntigensIBA 05/2006
1	CoagulantsIBA 04/2003
1	Factor VIII (Coagulation Factor VIII)IBA 04/2003
1	Factor VII (Proconvertin)IBA 01/2003
1	DNA (Deoxyribonucleic Acid)IBA 10/2002
1	ThrombomodulinIBA 02/2002

Therapy/Procedure

24	Therapeutics 11/2019 - 08/2003
4	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2010 - 02/2002
2	Radiotherapy 01/2017 - 01/2016
2	Estrogen Replacement Therapy 09/2003 - 02/2002
1	Aftercare (After-Treatment) 01/2017
1	Contraindications 01/2016
1	Ovariectomy (Oophorectomy) 03/2014
1	Contraception (Birth Control) 03/2011